Clinical Trial

Effects of Goji vs. Fiber on Macular Degeneration

Study acronym: GOJI
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this project is to conduct a clinical trial in 60 participants ranging from age 65-95 who are at risk for age-related macular degeneration (AMD). The study will evaluate the effects of 14g of goji berry intake or an equivalent amount and type of fiber, five days a week for six months, on visual health, gut microbiome profiles, skin carotenoid measures, and lipoprotein profiles.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-30 -> 2027-06-30 2026-07-19
minor Completion pushed: 2027-06-30 -> 2027-12-31 2026-07-19
Trial Details
NCT Number NCT06237127
Lead Sponsor University of California, Davis
Collaborators: United States Department of Agriculture (USDA)
Conditions Age-Related Macular Degeneration
Enrollment 60 participants
Start Date 2024-04-29
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-17